Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies
Clinical trial NCT05210062 · UNKNOWN
Trial details
- NCT number
- NCT05210062
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-27
- Primary completion
- 2023-09-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.